Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Omada Health, Inc. (OMDA:NASDAQ), powered by AI.
Omada Health, Inc. is currently trading at $17.11. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Omada Health, Inc. on Alpha Lenz.
Omada Health, Inc.'s P/E ratio is -49.1.
“Omada Health, Inc. trades at a P/E of -49.1 (undervalued) with modest ROE of -8.7%.”
Ask for details →Omada Health Inc. is a healthcare technology company specializing in virtual-first care programs focused on chronic disease prevention and management. Founded in 2011 and headquartered in San Francisco, the company delivers digital solutions designed to support individuals in managing conditions such as diabetes, hypertension, and musculoskeletal disorders. Omada Health provides personalized care plans that combine human coaching, connected smart health devices, and interactive digital tools to guide members toward sustainable lifestyle changes. The company's services are tailored for employers, health plans, health systems, pharmacy benefit managers, and other organizations seeking to improve health outcomes and reduce long-term care costs. With a user-centric approach, Omada Health has served over a million members and collaborates with thousands of corporate partners across diverse sectors, including education, retail, and manufacturing. By leveraging data-driven insights and a multidisciplinary care team, Omada Health plays a pivotal role in the health information services sector, aiming to "bend the curve" of chronic disease through accessible, engaging, and effective virtual care solutions.
“Omada Health, Inc. trades at a P/E of -49.1 (undervalued) with modest ROE of -8.7%.”
Ask for details →Omada Health, Inc. (ticker: OMDA) is a company listed on NASDAQ in the Healthcare sector (Health Information Services). It has approximately 859 employees. Market cap is $627M.
The current price is $17.11 with a P/E ratio of -49.06x and P/B of 2.73x.
ROE is -8.68% and operating margin is -4.60%. Annual revenue is $260M.